These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 16132406)
1. Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. Hesse UJ; DeDecker C; Houtmeyers P; Demetter P; Ceelen W; Pattyn P; Troisi R; deHemptinne B World J Surg; 2005 Oct; 29(10):1325-8. PubMed ID: 16132406 [TBL] [Abstract][Full Text] [Related]
2. Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy. Hesse UJ; De Decker C; Houtmeyers P; Demetter P; Ceelen W; Pattyn P; Troisi R; de Hemptinne B Acta Chir Belg; 2005 Aug; 105(4):383-7. PubMed ID: 16184721 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy. You DD; Paik KY; Park IY; Yoo YK Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436 [TBL] [Abstract][Full Text] [Related]
4. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial. Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders. Friess H; Büchler MW Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484 [TBL] [Abstract][Full Text] [Related]
6. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage. Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328 [TBL] [Abstract][Full Text] [Related]
7. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392 [TBL] [Abstract][Full Text] [Related]
8. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy]. Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933 [TBL] [Abstract][Full Text] [Related]
9. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery. Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293 [TBL] [Abstract][Full Text] [Related]
10. The role of octreotide in the prevention of complications following pancreatic resection. Berberat PO; Friess H; Uhl W; Büchler MW Digestion; 1999; 60 Suppl 2():15-22. PubMed ID: 10207227 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Pederzoli P; Bassi C; Falconi M; Camboni MG Br J Surg; 1994 Feb; 81(2):265-9. PubMed ID: 8156354 [TBL] [Abstract][Full Text] [Related]
13. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Friess H; Beger HG; Sulkowski U; Becker H; Hofbauer B; Dennler HJ; Büchler MW Br J Surg; 1995 Sep; 82(9):1270-3. PubMed ID: 7552016 [TBL] [Abstract][Full Text] [Related]
14. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Lai EC; Lau SH; Lau WY Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946 [TBL] [Abstract][Full Text] [Related]
15. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J; Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886 [TBL] [Abstract][Full Text] [Related]
16. Prevention of postoperative complications following pancreatic surgery. Büchler M; Friess H Digestion; 1993; 54 Suppl 1():41-6. PubMed ID: 8103013 [TBL] [Abstract][Full Text] [Related]
17. Short-term outcome of new end-to-side inserting pancreatico-jejunostomy without stiches on the pancreatic cut end. Hashimoto D; Hirota M; Chikamoto A; Beppu T; Baba H Hepatogastroenterology; 2014; 61(130):489-92. PubMed ID: 24901168 [TBL] [Abstract][Full Text] [Related]
18. Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial. Kurumboor P; Palaniswami KN; Pramil K; George D; Ponnambathayil S; Varma D; Aikot S J Gastrointest Surg; 2015 Nov; 19(11):2038-44. PubMed ID: 26302879 [TBL] [Abstract][Full Text] [Related]
19. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Büchler M; Friess H; Klempa I; Hermanek P; Sulkowski U; Becker H; Schafmayer A; Baca I; Lorenz D; Meister R Am J Surg; 1992 Jan; 163(1):125-30; discussion 130-1. PubMed ID: 1733360 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany. Fiess H; Klempa I; Hermanek P; Sulkowski U; Uhl W; Beger HG; Büchler MW Digestion; 1994; 55 Suppl 1():35-40. PubMed ID: 8132135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]